Evidence map›Paper›PMID 40141064›Full record

ReviewInternational journal of molecular sciences2025

Zα and Zβ Localize ADAR1 to Flipons That Modulate Innate Immunity, Alternative Splicing, and Nonsynonymous RNA Editing.

Alan Herbert, Oleksandr Cherednichenko, Terry P Lybrand, Martin Egli, Maria Poptsova

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. G-Quadruplexes Abet Neuronal Burnout in ALS and FTD.Antioxidants (Basel, Switzerland) · 2025
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alan HerbertDiscovery, InsideOutBio, Charlestown, MA 02129, USA.ORCID 0000-0002-0093-1572
Oleksandr CherednichenkoInternational Laboratory of Bioinformatics, HSE University, 101000 Moscow, Russia.
Terry P LybrandDepartment of Chemistry, School of Medicine, Vanderbilt University, Nashville, TN 37232-0146, USA.
Martin EgliDepartment of Biochemistry, School of Medicine, Vanderbilt University, Nashville, TN 37232-0146, USA.ORCID 0000-0003-4145-356X
Maria PoptsovaInternational Laboratory of Bioinformatics, HSE University, 101000 Moscow, Russia.ORCID 0000-0002-7198-8234

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The double-stranded RNA editing enzyme ADAR1 connects two forms of genetic programming, one based on codons and the other on flipons. ADAR1 recodes codons in pre-mRNA by deaminating adenosine to form inosine, which is translated as guanosine. ADAR1 also plays essential roles in the immune defense against viruses and cancers by recognizing left-handed Z-DNA and Z-RNA (collectively called ZNA). Here, we review various aspects of ADAR1 biology, starting with codons and progressing to flipons. ADAR1 has two major isoforms, with the p110 protein lacking the p150 Zα domain that binds ZNAs with high affinity. The p150 isoform is induced by interferon and targets ALU inverted repeats, a class of endogenous retroelement that promotes their transcription and retrotransposition by incorporating Z-flipons that encode ZNAs and G-flipons that form G-quadruplexes (GQ). Both p150 and p110 include the Zβ domain that is related to Zα but does not bind ZNAs. Here we report strong evidence that Zβ binds the GQ that are formed co-transcriptionally by ALU repeats and within R-loops. By binding GQ, ADAR1 suppresses ALU-mediated alternative splicing, generates most of the reported nonsynonymous edits and promotes R-loop resolution. The recognition of the various alternative nucleic acid conformations by ADAR1 connects genetic programming by flipons with the encoding of information by codons. The findings suggest that incorporating G-flipons into editmers might improve the therapeutic editing efficacy of ADAR1.

Indexed as

Adenosine DeaminaseAlternative SplicingDNA, Z-FormImmunity, InnateRNA-Binding ProteinsRNA EditingAlu ElementsAnimalsG-QuadruplexesHumansADAR protein, humanAdenosine DeaminaseDNA, Z-FormRNA-Binding ProteinsADAR1ALU repeatsfliponsG-quadruplexR-loopsRNA editingRNA splicingZ-RNA

Identifiers

PMID40141064
PMCPMC11942513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.